Both in Pharmaceuticals
Korsana Biosciences vs Pacira BioSciences
Over the past year KRSA returned −0.8% and PCRX returned +43.5%; their daily moves had a correlation of 0.25.
KRSA −0.8% PCRX +43.5%Growth of $1, one year, split-adjusted
| Metric | KRSA | PCRX |
|---|---|---|
| Price | $31.66 | $36.40 |
| Market cap | $1.44B | $1.45B |
| Today | +5.04% | +0.03% |
| 1 month | +3.8% | +44.4% |
| 6 months | — | +47.4% |
| Year to date | — | +40.6% |
| 1 year | — | +71.1% |
| Revenue growth (YoY) | — | +6.2% |
| Gross margin | — | 77.0% |
| Net margin | — | 2.4% |
| P/E (TTM) | — | 99.2× |
| Price / sales | — | 1.9× |
| Net cash | — | -$112.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 78.7% |
| Short % of float | 1.0% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).